BORDERI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.989
AS - Asia 1.675
EU - Europa 1.204
AF - Africa 139
SA - Sud America 60
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.073
Nazione #
US - Stati Uniti d'America 1.977
VN - Vietnam 580
SG - Singapore 405
CN - Cina 389
GB - Regno Unito 288
SE - Svezia 196
DE - Germania 170
IT - Italia 150
HK - Hong Kong 105
FR - Francia 82
RU - Federazione Russa 74
IN - India 62
IE - Irlanda 58
TG - Togo 53
BR - Brasile 47
UA - Ucraina 45
NL - Olanda 42
ZA - Sudafrica 34
JO - Giordania 33
EE - Estonia 26
CI - Costa d'Avorio 22
NG - Nigeria 22
JP - Giappone 21
FI - Finlandia 18
BG - Bulgaria 17
TH - Thailandia 15
PH - Filippine 11
AR - Argentina 9
BE - Belgio 8
CA - Canada 8
KR - Corea 8
PK - Pakistan 7
BD - Bangladesh 6
ES - Italia 6
IR - Iran 6
AT - Austria 4
CH - Svizzera 4
IQ - Iraq 4
PL - Polonia 4
UZ - Uzbekistan 4
AU - Australia 3
ID - Indonesia 3
MY - Malesia 3
TR - Turchia 3
TW - Taiwan 3
EC - Ecuador 2
ET - Etiopia 2
GR - Grecia 2
MX - Messico 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.073
Città #
Singapore 278
Southend 257
Ashburn 205
Fairfield 202
Chandler 158
Ho Chi Minh City 125
San Jose 124
Hanoi 104
Woodbridge 103
Hong Kong 102
Seattle 100
Santa Clara 95
Wilmington 88
Dong Ket 84
Houston 83
Cambridge 77
Ann Arbor 72
Princeton 69
Dublin 58
Beijing 53
Lomé 53
Bologna 45
Boardman 38
Amman 33
Nanjing 32
Westminster 30
Padova 29
Lauterbourg 28
Dearborn 27
Da Nang 26
Los Angeles 24
Abeokuta 22
Abidjan 22
Turin 22
Haiphong 21
Berlin 20
Jacksonville 20
Hefei 19
Hebei 18
Milan 18
Shenyang 18
Munich 17
Sofia 17
San Diego 16
Saint Petersburg 15
Helsinki 14
Tokyo 14
Florence 13
Frankfurt am Main 13
Jinan 13
Buffalo 12
New York 12
Tianjin 12
Des Moines 11
Jiaxing 11
Shanghai 11
Orem 10
Phoenix 10
Redondo Beach 10
Atlanta 9
Bremen 9
Hangzhou 9
Brussels 8
Changsha 8
Düsseldorf 8
Guangzhou 8
Nanchang 8
Mülheim 7
Thái Nguyên 7
Zhengzhou 7
Bangkok 6
Biên Hòa 6
Can Tho 6
Dallas 6
Ha Long 6
Hải Dương 6
Olalla 6
São Paulo 6
Wuhan 6
Chicago 5
Falls Church 5
Harbin 5
Kunming 5
Monmouth Junction 5
Nha Trang 5
Norwalk 5
San Francisco 5
San Mauro Pascoli 5
Yubileyny 5
Bến Tre 4
Falkenstein 4
Haikou 4
Lanzhou 4
London 4
Moscow 4
Ningbo 4
Nuremberg 4
Paris 4
Quận Một 4
Rio de Janeiro 4
Totale 3.469
Nome #
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management 289
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 236
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 225
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 199
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 195
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 189
Antiretroviral molecules and cardiovascular diseases. 188
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 184
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 181
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 181
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 181
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008 177
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 175
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 170
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 169
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 165
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 165
Bone alterations during HIV infection 164
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir 162
Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention. 161
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 161
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study 159
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 147
Metabolic bone disease in HIV infection 146
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 143
Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management. 141
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. 133
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. 131
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group. 123
Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? 112
Totale 5.152
Categoria #
all - tutte 12.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 12 12 167
2021/2022610 31 25 36 90 50 33 9 48 13 76 114 85
2022/2023736 64 108 33 96 57 49 11 42 147 23 76 30
2023/2024147 9 26 15 19 11 36 9 5 1 14 2 0
2024/2025647 26 85 45 46 130 42 33 21 3 61 10 145
2025/20261.446 115 185 110 106 165 76 216 64 318 91 0 0
Totale 5.152